An agenda for research on adverse drug reactions.

An agenda for research on adverse drug reactions.

Detalles Bibliográficos
Autor Principal:	Aronson, J
Formato:	Journal article
Idioma:	English
Publicado:	2007

Títulos similares

Pharmacogenetics and adverse drug reactions
por: Ferner, R, et al.
Publicado: (2010)

Adverse drug reactions--no farewell to harms.
por: Aronson, J
Publicado: (2007)

Publishing histories of adverse reactions to medicaments anecdotally: the PHARMA guidelines for reporting suspected adverse drug reactions.
por: Aronson, J
Publicado: (2008)

Adverse drug reactions: definitions, diagnosis, and management.
por: Edwards, I, et al.
Publicado: (2000)

Adverse drug reactions: keeping up to date.
por: Aronson, J, et al.
Publicado: (2002)

Distinguishing hazards and harms, adverse drug effects and adverse drug reactions : implications for drug development, clinical trials, pharmacovigilance, biomarkers, and monitoring.
por: Aronson, J
Publicado: (2013)

National differences in publishing papers on adverse drug reactions.
por: Ferner, R, et al.
Publicado: (2005)

Paradoxical reactions: Under-recognized adverse effects of drugs?
por: Hauben, M, et al.
Publicado: (2006)

Stephens' Detection and Evaluation of Adverse Drug Reactions: Principles and Practice
por: Talbot, J, et al.
Publicado: (2012)

Stephens' Detection and Evaluation of Adverse Drug Reactions: Principles and Practice
por: Talbot, J, et al.
Publicado: (2012)

Adverse Drug Reactions: History, Terminology, Classification, Causality, Frequency, Preventability
por: Aronson, J
Publicado: (2012)

Meyler's side effects of drugs : the international encyclopedia of adverse drug reactions and interactions /
por: Aronson, Jeffrey K.
Publicado: (2006)

Joining the DoTS: new approach to classifying adverse drug reactions.
por: Aronson, J, et al.
Publicado: (2003)

Unity from diversity: the evidential use of anecdotal reports of adverse drug reactions and interactions.
por: Aronson, J
Publicado: (2005)

Preventability of drug-related harms - part II: proposed criteria, based on frameworks that classify adverse drug reactions.
por: Aronson, J, et al.
Publicado: (2010)

A practical guide to monitoring for adverse drug reactions during antihypertensive drug therapy.
por: McDowell, SE, et al.
Publicado: (2013)

Stephens' detection and evaluation of adverse drug reactions : principles and practice /
por: Talbot, J. C. C., et al.
Publicado: (2012)

Incomplete evidence: the inadequacy of databases in tracing published adverse drug reactions in clinical trials
por: Derry, S, et al.
Publicado: (2001)

Incomplete evidence: The inadequacy of databases in tracing published adverse drug reactions in clinical trials
por: Derry, S, et al.
Publicado: (2001)

Case reports of suspected adverse drug reactions--systematic literature survey of follow-up.
por: Loke, Y, et al.
Publicado: (2006)

Post-marketing withdrawal of analgesic medications because of adverse drug reactions: a systematic review
por: Onakpoya, I, et al.
Publicado: (2017)

Worldwide withdrawal of medicinal products because of adverse drug reactions: a systematic review and analysis
por: Onakpoya, I, et al.
Publicado: (2016)

Gold standards in pharmacovigilance: the use of definitive anecdotal adverse drug reactions as pure gold and high grade ore
por: Hauben, M, et al.
Publicado: (2006)

Incomplete evidence: the inadequacy of databases in tracing published adverse drug reactions in clinical trials
por: Aronson Jeffrey K, et al.
Publicado: (2001-09-01)

Gold standards in pharmacovigilance: the use of definitive anecdotal reports of adverse drug reactions as pure gold and high-grade ore.
por: Hauben, M, et al.
Publicado: (2007)

Monitoring for the Adverse Effects of Drugs
por: Coleman, J, et al.
Publicado: (2008)

Post-marketing withdrawal of anti-obesity medicinal products because of adverse drug reactions: a systematic review.
por: Onakpoya, I, et al.
Publicado: (2016)

Signals of adverse drug reactions communicated by pharmacovigilance stakeholders: protocol for a scoping review of the global literature
por: Daniele Sartori, et al.
Publicado: (2020-08-01)

Adverse cutaneous drug reaction
por: Nayak Surajit, et al.
Publicado: (2008-01-01)

Clinical pharmacology. Adverse drug interactions.
por: Aronson, J, et al.
Publicado: (1981)

Research Progress on Mechanism and Management of Adverse Drug Reactions of Anlotinib
por: Li S, et al.
Publicado: (2023-11-01)

Adverse drug reactions and causality: the Turkish version of Naranjo Adverse Drug Reactions Probability Scale
por: Samet Kose, et al.
Publicado: (2017-04-01)

EIDOS: a mechanistic classification of adverse drug effects.
por: Ferner, R, et al.
Publicado: (2010)

Post-marketing withdrawal of 462 medicinal products because of adverse drug reactions: a systematic review of the world literature
por: Onakpoya, IJ, et al.
Publicado: (2016)

Pharmacovigilance and reporting adverse drug reactions.
por: Isa NM,
Publicado: (2014)

Children and ADRs (Adverse Drug Reactions)
por: Napoleone Ettore
Publicado: (2010-01-01)

Adverse Drug Reactions in the Oral Cavity
por: Danko Velimir Vrdoljak, et al.
Publicado: (2015-01-01)

Case reports and adverse drug reactions
por: Igić Rajko, et al.
Publicado: (2013-01-01)

Pharmacogenetics of adverse reactions to antiepileptic drugs
por: I. Fricke-Galindo, et al.
Publicado: (2018-04-01)

MRGPRX2 and Adverse Drug Reactions
por: Benjamin D. McNeil
Publicado: (2021-08-01)